Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy

• Дата: 2023
• Автори: Perekhrestenko, T., Melnyk, U., Goryainova, N., Diagil, I.
• Формат: Стаття
• Мова: English
• Опубліковано: PH Akademperiodyka 2023
• Теми: CD34+ cells; chronic myeloid leukemia; imatinib; nilotinib; Кі-67
• Онлайн доступ: https://exp-oncology.com.ua/index.php/Exp/article/view/2020-2-3
• Назва журналу: Experimental Oncology

Summary. Aim: To assess the expression of Ki-67 protein and CD34 antigen on peripheral blood (PB) and bone marrow (BM) cells in chronic myelogenous leukemia (CML) patients with different response to tyrosine kinase inhibitors (TKI) imatinib (IM) and nilotinib (NI) therapy. Patients...